Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

Biotech's reverse merger renaissance poised to continue

A biotech collected $820 million in investor commitments this month to take its China-sourced immunology drug onto the public markets. That would make it one of the largest, if not the ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Monday 17 August →